Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Amortization of Deferred Charges (2020 - 2023)

RxSight's Amortization of Deferred Charges history spans 4 years, with the latest figure at $4000.0 for Q3 2023.

  • For Q3 2023, Amortization of Deferred Charges fell 97.2% year-over-year to $4000.0; the TTM value through Jun 2024 reached $4000.0, down 99.3%, while the annual FY2023 figure was $287000.0, 48.01% down from the prior year.
  • Amortization of Deferred Charges reached $4000.0 in Q3 2023 per RXST's latest filing, down from $142000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $465000.0 in Q4 2021 to a low of -$201000.0 in Q3 2021.
  • Average Amortization of Deferred Charges over 4 years is $118083.3, with a median of $132500.0 recorded in 2022.
  • Peak YoY movement for Amortization of Deferred Charges: surged 447.06% in 2021, then crashed 97.2% in 2023.
  • A 4-year view of Amortization of Deferred Charges shows it stood at $85000.0 in 2020, then soared by 447.06% to $465000.0 in 2021, then plummeted by 69.03% to $144000.0 in 2022, then tumbled by 97.22% to $4000.0 in 2023.
  • Per Business Quant, the three most recent readings for RXST's Amortization of Deferred Charges are $4000.0 (Q3 2023), $142000.0 (Q2 2023), and $141000.0 (Q1 2023).